Related references
Note: Only part of the references are listed.Estimating the Risk of Vertical Transmission of Dengue: A Prospective Study
Celia Basurko et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Co-circulation of all the four dengue virus serotypes and detection of a novel clade of DENV-4 (genotype I) virus in Pune, India during 2016 season
Shubham Shrivastava et al.
PLOS ONE (2018)
ICTV Virus Taxonomy Profile: Flaviviridae
Peter Simmonds et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Prevention and Control Strategies to Counter Dengue Virus Infection
Irfan A. Rather et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Zika Virus Infection during Pregnancy and Congenital Abnormalities
Irfan A. Rather et al.
Frontiers in Microbiology (2017)
Epitopes based drug design for dengue virus envelope protein: A computational approach
Abdul Wadood et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2017)
The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries
Maira Aguiar et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial
Luis Javier Martinez et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
Bruno Guy et al.
VACCINE (2015)
Ultrastructural Characterization and Three-Dimensional Architecture of Replication Sites in Dengue Virus-Infected Mosquito Cells
Jiraphan Junjhon et al.
JOURNAL OF VIROLOGY (2014)
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
Jorge E. Osorio et al.
LANCET INFECTIOUS DISEASES (2014)
Human to mosquito transmiss on of dengue viruses
Lauren B. Carrington et al.
FRONTIERS IN IMMUNOLOGY (2014)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
Raphael M. Zellweger et al.
PLOS PATHOGENS (2013)
Evasion of the human innate immune system by dengue virus
Sarah Pagni et al.
IMMUNOLOGIC RESEARCH (2012)
Update on the global spread of dengue
Alfonso Guzman et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Development of a recombinant tetravalent dengue virus vaccine: Innmunogenicity and efficacy studies in mice and monkeys
David E. Clements et al.
VACCINE (2010)
Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites
Sonja Welsch et al.
CELL HOST & MICROBE (2009)
Evaluation of Commercially Available Anti-Dengue Virus Immunoglobulin M Tests
Elizabeth A. Hunsperger et al.
EMERGING INFECTIOUS DISEASES (2009)
A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus
Kanakatte Raviprakash et al.
JOURNAL OF VIROLOGY (2008)
Structure of the immature dengue virus at low pH primes proteolytic maturation
I-Mei Yu et al.
SCIENCE (2008)
Characterization of a dengiie patient cohort in Recife, Brazil
Marli Tenorio Cordeiro et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus
Justin R. Anderson et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2006)
Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults
S Kitchener et al.
VACCINE (2006)
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
JR Putnak et al.
VACCINE (2005)
A structural perspective of the Flavivirus life cycle
S Mukhopadhyay et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Structure of West Nile virus
S Mukhopadhyay et al.
SCIENCE (2003)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
N Kanesa-thasan et al.
VACCINE (2001)
An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients
PR Young et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2000)